Hongbin Ma
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Perioperative Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: a phase II trial.
Journal: Nature communications
Published: January 08, 2024
A Pilot Study on Human Circulating System Indicated That Regenerating Islet-Derived Protein 3 Gamma (REG3A) is a Potential Prognostic Biomarker for Sepsis.
Journal: The American journal of cardiology
Published: July 08, 2022
The Short-Range, High-Accuracy Compact Pulsed Laser Ranging System.
Journal: Sensors (Basel, Switzerland)
Published: January 20, 2022
LINC01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis.
Journal: American journal of translational research
Published: August 26, 2020
Mutant ACTB mRNA 3'-UTR promotes hepatocellular carcinoma development by regulating miR-1 and miR-29a.
Journal: Cellular signalling
Published: September 27, 2019
The LncRNA H19/miR-193a-3p axis modifies the radio-resistance and chemotherapeutic tolerance of hepatocellular carcinoma cells by targeting PSEN1.
Journal: Journal of cellular biochemistry
Published: January 02, 2018
MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: March 29, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026